Skip to main content
Clinical Trials/NL-OMON24504
NL-OMON24504RecruitingNot Applicable

Health-Related Quality of Life Assessment And Communication During 48 Weeks of Treatment of Moderate to Severe Psoriasis.

Stichting AquamarijnMeibergdreef 91105 AZ AMSTERDAM ZO0 sites200 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
200

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Eighteen years of age or older at time of consent.
  • 2. Established diagnosis of plaque psoriasis.

Exclusion Criteria

  • 1. Patients of childbearing potential who are not using or willing to use adequate anti-conceptive measures.
  • 2. Contraindications for the use of etanercept: sepsis or risk of sepsis, including local infections.

Investigators

Sponsor
Stichting AquamarijnMeibergdreef 91105 AZ AMSTERDAM ZO

Similar Trials